Manufacturing ExecutionOct 09, 20261.6 MB

Going paperless in pharmaceutical manufacturing: two strategies, the same gains

Organex Summit 2026 white paper with the lessons Biolab and Theraskin shared on moving pharmaceutical manufacturing off paper. It covers two NEO rollout strategies, the gains the companies presented, how they justified the investment and a readiness checklist.

Checking your access…

What you will find

Biolab and Theraskin took their manufacturing off paper with NEO, from T2 Software, by different paths and with similar gains. This material summarizes what the two companies shared at the "Digital Maturity in Life Sciences" roundtable at the 1st Organex Summit, in São Paulo, on October 7, 2026, moderated by Rodrigo Klein.

  • Two rollout strategies: plant by plant and from the ground up.
  • The gains the companies presented, such as batch record review by exception, weighing without manual entry and cleaning status in the system.
  • Four points of attention to reach the gains faster.
  • How each company justified the investment to its board.
  • A readiness checklist to take to your next meeting with production and quality.

The numbers are the ones the companies presented at the Summit and have not been audited.

Who it is for

Plant management, manufacturing, quality and digital transformation leaders in Life Sciences companies.

See also

The recording of the full panel is in the materials area, linked to this white paper.

  • EBR
  • Case

Related material

  • 47:43
    Video
    1st Organex Digitalization Summit - Biolab and Theraskin Case Study

    Roundtable at the Organex Summit "Digital Maturity in Life Sciences": Biolab and Theraskin tell, through the voice of those who implemented it, how they took manufacturing off paper with NEO, from T2 Software. There are two different strategies. Biolab turned plant by plant to a totally digital operation, starting with the softgel plant, with a team dedicated to digital transformation. Theraskin followed a phased approach: first the base (production flow, cleaning, weighing), with key users from each area, and now EBR and production planning. In the conversation: what went right and what went wrong, the first paperless inspection, the challenge of having each operator register presence in the order, lot record review by exception, and how to justify the investment to the board. With Paulo Cesar Fernandes (Theraskin) and Luiz Sofia (Biolab). Moderation: Rodrigo Klein (T2 Software).